Response to: Correspondence on "ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update " by Ramiro et al

S. Ramiro; E. Nikiphorou; A. Sepriano; A. Ortolan; C. Webers; X. Baraliakos; R.B. Landewe; D. van der Heijde

doi:10.1136/ard-2023-223937

Response to: Correspondence on "ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update " by Ramiro et al

S. Ramiro^*, E. Nikiphorou, A. Sepriano, A. Ortolan, C. Webers, X. Baraliakos, R.B. Landewe, D. van der Heijde

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Article number	e206
Pages (from-to)	E206
Number of pages	2
Journal	Annals of the Rheumatic Diseases
Volume	82
Issue number	9
Early online date	1 Mar 2023
DOIs	https://doi.org/10.1136/ard-2023-223937
Publication status	Published - Sept 2023

Keywords

Spondylitis
Ankylosing
Epidemiology
Biological Therapy
EFFICACY

Access to Document

10.1136/ard-2023-223937

Cite this

@article{e20591dbbf2348359003bde1003d7231,

title = "Response to: Correspondence on {"}ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update {"} by Ramiro et al",

keywords = "Spondylitis, Ankylosing, Epidemiology, Biological Therapy, EFFICACY",

author = "S. Ramiro and E. Nikiphorou and A. Sepriano and A. Ortolan and C. Webers and X. Baraliakos and R.B. Landewe and {van der Heijde}, D.",

year = "2023",

month = sep,

doi = "10.1136/ard-2023-223937",

language = "English",

volume = "82",

pages = "E206",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

number = "9",

}

TY - JOUR

T1 - Response to: Correspondence on "ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update " by Ramiro et al

AU - Ramiro, S.

AU - Nikiphorou, E.

AU - Sepriano, A.

AU - Ortolan, A.

AU - Webers, C.

AU - Baraliakos, X.

AU - Landewe, R.B.

AU - van der Heijde, D.

PY - 2023/9

Y1 - 2023/9

KW - Spondylitis

KW - Ankylosing

KW - Epidemiology

KW - Biological Therapy

KW - EFFICACY

U2 - 10.1136/ard-2023-223937

DO - 10.1136/ard-2023-223937

M3 - Comment/Letter to the editor

C2 - 36878690

SN - 0003-4967

VL - 82

SP - E206

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - 9

M1 - e206

ER -